A course of antenatal corticosteroids given within the seven days prior to preterm birth
reduces perinatal and neonatal death and respiratory distress syndrome.[Grade A] For …

OBJECTIVES: To assess the benefits and risks of antenatal corticosteroid therapy for fetal
maturation. OPTIONS: To administer antenatal corticosteroids or not to women at risk of …

No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Objective The purpose of this review is to describe the historical and scientific basis of
antenatal corticosteroids (ACS) therapy, to improve the management of preterm birth and …

OBJECTIVE: To document current use of antenatal corticosteroid therapy in a large cohort of
Canadian preterm infants admitted to neonatal intensive care units, and to assess the impact …

For women with a singleton or a multiple pregnancy in situations where active neonatal care
is appropriate, and for whom preterm birth is anticipated between 24 and 34 weeks of …

The practice of antenatal corticosteroid administration in pregnancies of 24–34 weeks of
gestation that are at risk of preterm delivery was adopted over 20 years after the first …

Antenatal corticosteroids are standard of care for pregnancies at risk of preterm delivery
between 24-34 weeks' gestational age. Recent trials demonstrate modest benefits from …

Background Respiratory distress syndrome is a serious complication of prematurity causing
significant immediate and long‐term mortality and morbidity. Objectives The objective of this …

Objectives: To determine the risk of fetal, neonatal and maternal mortality and morbidity for
women and their infants who remained undelivered more than 7 days following a course of …